US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a

CD56 Antibody, anti-human, REAfinity™

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

A 3D primary human cell-based in vitro model of non-alcoholic

T cell immunotherapy for cardiac fibrosis: mRNA starts the CAR

Investigating fibrosis and inflammation in an ex vivo NASH murine

CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated

Targeting CD301+ macrophages inhibits endometrial fibrosis and

Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.

CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5